Protective effect of omeprazole against acute gastric mucosal lesions induced by compound 48/80, a mast cell degranulator, in rats

Pharmacological Research

Volumn 46, Issue 1, 2002, Pages 75-84

  Kobayashi, Takashi ^a   Ohta, Yoshiji ^b   Inui, Kazuo ^a   Yoshino, Junji ^a   Nakazawa, Saburo ^a  

^a FUJITA HEALTH UNIVERSITY BANTANE HOSPITAL   (Japan)

^b FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

Compound 48 80; Gastric mucosal lesion (rat); Lipid peroxidation; Neutrophil infiltration; Omeprazole

Indexed keywords

ACID; COMPOUND 48-80; HEXOSAMINE; LIPID; LIPID PEROXIDE; MUCIN; MYELOPEROXIDASE; OMEPRAZOLE; THIOL DERIVATIVE; XANTHINE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME ASSAY; LIPID PEROXIDATION; MALE; MAST CELL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTECTION; PROTEIN DEPLETION; RAT; STOMACH MUCOSA; STOMACH MUCOSA LESION; TIME;

EID: 0036421210     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-6618(02)00034-8     Document Type: Article

References (59)

1. Olbe L, Haglund U, Leth R, Lind T, Cederberg C, Ekenved G, Elander B, Fellenius E, Lunfborg P, Wallmark B. Effect of substituted benzimidazole (H149/94) on gastric acid secretion in humans. Gastroenterology 1982; 83: 193-8.
2. Lind T, Cederberg C, Ekenved G, Haglund U, Olbe L. Effect of omeprazole-a gastric proton pump inhibitor-on pentagastrin stimulated acid secretion in man. Gut 1983; 24: 270-6.
3. Larsson H, Carlsson E, Junggren U, Olbe L, Sjöstrand S-E, Skånberg I, Sundell G. Inhibition of gastric acid secretion by omeprazole in the dog and rat. Gastroenterology 1983; 85: 900-7.
4. Yamamoto O, Okada Y, Okabe S. Effects of a proton pump inhibitor, omeprazole, on gastric acid secretion and gastric and duodenal ulcers or erosions in rats. Dig Dis Sci 1984; 29: 394-401.
5. 2-receptor antagonist, famotidine (FMD). Folia Pharmacol Jpn (Nippon Yakuri Gakkai Zassghi) 1988; 92: 39-47.
6. +) ATPase. Nature 1981; 290: 159-61.
7. +)-ATPase by omeprazole in isolated gastric vesicles requires proton transport. Biochim Biophys Acta 1987; 897: 41-51.
8. Brunner G, Chang J. Intravenous therapy with high doses of ranitidine and omeprazole in critically ill patients with bleeding peptic ulcerations on the upper intestinal track: An open randomized controlled trial. Digestion 1990; 45: 217-25.
9. Khuroo MS, Yattoo GN, Javid G, Khan BA, Shah AA, Gulzar GM, Sodi JS. A comparison of omeprazole and placebo for bleeding peptic ulcer. N Engl J Med 1997; 336: 1054-8.
10. Mattsson H, Andersson K, Larsson H. Omeprazole provides protection against experimentally induced gastric mucosal lesions. Eur J Pharmacol 1983; 91: 111-4.
11. Konturek SJ, Brzozowski T, Radecki T. Protective action of omepra-zole a benzimidazole derivative, on gastric mucosal damage by aspirin and ethanol in rats. Digestion 1983; 27: 159-64.
12. Ohara S, Murayama N, Kuwata H, Ishihara K, Hotta K. Effect of omeprazole on rat gastric mucus glycoproteins with acetylsalicylic acid-induced gastric damage. Arch Int Pharmacodyn 1988; 296: 192-201.
13. Blandizzi C, Gheradi G, Natale G, Marveggio C, Del Tacca M. Protective action of omeprazole against gastric mucosal injury induced by hemorrhagic shock in rats. Dig Dis Sci 1994; 39: 2109-17.
14. Blandizzi C, Gheradi G, Marveggio G, Natale G, Carignari D, Del Tacca M. Mechanisms of protection by omeprazole against experimental gastric mucosal damage in rats. Digestion 1995; 56: 220-9.
15. Blandizzi C, Nalae G, Gheradi G, Lazzeri G, Mareggio C, Colucci R, Carignani D, Del Tacca M. Gastroprotective effects of pantoprazole against experimental mucosal damage. Fundam Clin Pharmaocol 2000; 14: 89-99.
16. Piotrowski J, Piotrowski E, Skrodzka D, Slomiany A, Slomiany BL. Gastric mucosal apoptosis induced by ethanol: Effect of antiulcer agents. Biochem Mol Biol Int 1997; 42: 247-54.
17. Slomiany BL, Piotrowaki J, Slomiany A. Role of endothelin-1 and constitutive nitric oxide synthase in gastric mucosal resistance to indomethacin injury: Effect of antiulcer agents. Scand J Gastroenterol 1999; 34: 459-64.
18. Ohtsuki H, Takeuchi K, Okabe S. Role of gastric acid and bile acids in the pathogenesis of compound 48/80-induced gastric lesions in rats. Jpn J Pharmacol 1985; 38: 253-7.
19. Wandall JH. Effects of omeprazole on neutrophil chemotaxis, superoxide production, degradation, and translocation of cytochrome b-245. Gut 1992; 33: 617-21.
20. Suzuki M, Mori M, Fukumura D, Suzuki H, Miura S, Ishii H. Omeprazole attenuates neutrophil-endothelial cell adhesive interaction induced by extracts of Helicobacter pylori. J Gastroenterol Hepatol 1999; 14: 27-31.
21. Holbauer R, Loset H, Gmeiner B, Wagner O, Kapitotis S, Frass M, Kaye AD. Inhibitory effect of omeprazole on transmigration of leukocytes through endothelial cell monolayer and leukocyte adhesion. Microvasc Res 2000; 59: 169-71.
22. Suzuki M, Mori M, Miura S, Suematsu M, Fukumura D, Kimura H, Ishii H. Omeprazole attenuates oxygen-derived free radical production from human neutrophils. Free Radic Biol Med 1996; 21: 727-31.
23. Lapenna D, de Gioia S, Ciofani G, Festi D, Cuccurullo F. Antioxidant properties of omeprazole. FEBS Lett 1996; 382: 189-92.
24. Laine L, Frantz JE, Baker A, Neil GA. A United State multicentre trial of dual and proton pump inhibitor-based triple therapies for Helicobacter pylori. Aliment Pharmacol Ther 1997; 11: 913-7.
25. Carratue R, Iuliano D, Iovene MR, Ferraracio F, Esposito P, Russo MI, Montella F, Abbate G, Tufano MA. Peptic ulcer occurrence on follow-up of chronic gastritis in patients with treated and not eradicated CagA-positive Helicobacter pyroli infection. Dig Dis Sci 2001; 46: 581-6.
26. Larkin CJ, Watson P, Sloan JM, Ardill JE, Patterson CC, McCluggage WG, Buchanan KD. Gastric corpus atrophy following eradication of Helicobacter pyroli. Eur J Gastroenterol Hepatol 2001; 13: 377-82.
27. Yamamoto J, Watanabe S, Hirose M, Osada T, Ra C, Sato N. Role of mast cells as a trigger of inflammation in Helicobacter pylori infection. J Physiol Pharmacol 1999; 50: 1-17.
28. Atuma C, Engstrand L, Holm L. Helicobacter pylori extracts reduce gastric mucosal blood flow by a nitric oxide-independent but mast cell- and platelet-activating factor receptor-dependent pathway in rats. Scand J Gastroenterol 1999; 34: 1183-9.
29. Ohta Y, Kobayashi T, Nishida K, Ishiguro I. Relationship between changes of active oxygen metabolism and blood flow and formation, progression, and recovery of lesions in gastric mucosa of rats with a single treatment of compound 48/80, a mast cell degranulator. Dig Dis Sci 1997; 42: 1221-32.
30. Ohta Y, Kobayashi T, Ishiguro I. Participation of xanthine-xanthine oxidase system and neutrophils in development of acute gastric mucosal lesions in rats with a single treatment of compound 48/80, a mast cell degranulator. Dig Dis Sci 1999; 44: 1865-74.
31. Ohta Y, Kobayashi T, Ishiguro I. Role of endogenous serotonin and histamine in the pathogenesis of gastric mucosal lesions in unanesthetised rats with a single treatment of compound 48/80, a mast cell degranulator. Pharmacol Res 1999; 39: 261-7.
32. Krawisz JE, Sharon P, Stenson WF. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 1984; 87: 1344-50.
33. Ishihara K, Morishita K, Ohara S, Ohkawa H, Kameyama Y, Hotta K. Analysis of gastric mucosal hexosamine for the determination of gastric mucus content. Jpn J Gastroenterol (Nippon Shokakibyo Gakkai Zasshi) 1989; 86: 111.
34. Suzuki K, Ota H, Sasagawa S, Sakatani T, Fujikura T. Assay method for myeloperoxidase in human polymorphonuclear leukocytes. Anal Biochem 1983; 132: 345-53.
35. Hashimoto S. New spectrophotometric assay method of xanthine oxidase in crude tissue homogenate. Anal Biochem 1974; 62: 426-33.
36. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-8.
37. Sedlak J, Lindsay RH. Estimation of total, protein-bound, and non-protein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem 1968; 25: 192-205.
38. Oketani K, Murakami M, Fujisawa H, Wakabayashi T. Rapid determination for the hexosamine content as an indicator of the mucus glycoproteins in biopsy sample from alimentary track. J Clin Exp Med (Igaku no Ayumi) 1984; 131: 745-9.
39. Kitagawa H, Takada F, Kohei H. A simple method for estimation of gastric mucus and effects of antiulcernogenic agents on the decrease in mucus during water-immersion stress in rats. Arzneim Forsch/Drug Res 1986; 36: 1240-4.
40. Shibata K, Onodera M, Kawada T, Iwai K. Simultaneous micro-determination of serotonin and 5-hydroxyindole-3-acetic acid with 5-hydroxy-Nω-methyltryptamine, as an internal standard, in biological materials by high-performance liquid chromatography with electrochemical detection. J Chromatogr 1988; 430: 381-7.
41. Lorenz W, Reimann H-J, Barth H, Kushe J, Meyer R, Doenicke A, Hutzel M. A sensitive and specific method for the determination of histamine in human whole blood and plasma. Hoppe-Seyler's Z Physiol Chem 1972; 127: 182-6.
42. Shore PA, Burkhalter A, Cohn VH Jr. A method for the fluorometric assay of histamine in tissues. J Phamacol Exp Ther 1959; 127: 182-6.
43. Hus HC, Flancaum LJ, Kasziba E, Merril GF, Fischer H. Role of in vitro- and in vivo-administered histamine and serotonin in compound 48/80-induced gastric acid secretion in isolated perfused rat stomach. Dig Dis Sci 1991; 36: 1708-14.
44. Takeuchi K, Ohtsuki H, Okabe S. Pathogenesis of compound 48/80-induced gastric mucosal lesions in rats. Dig Dis Sci 1986; 31: 392-400.
45. Holm-Rutili L. Effects of omeprazole on gastric mucosal microcirculation and acid secretion in the rat. Gastroenterology 1987; 92: 716-23.
46. Hui WM, Chen BW, Cho CH, Luk CT, Lam SK. Role of gastric mucosal blood flow in cytoprotection. Digestion 1991; 48: 113-20.
47. 2 receptors in gastric mucosal blood flow. Scand J Gastroenterol 1987; 22: 250-2.
48. Mattsson H, Larsson H. Effects of omeprazole on gastric mucosal blood flow in the conscious rat. Scand J Gastroenterol 1987; 22: 491-8.
49. Kobayashi T, Ohta Y, Yoshino J. Preventive effect of ebselen on acute gastric mucosal lesion development in rats treated with compound 48/80. Eur J Pharmacol 2001; 412: 271-9.
50. Kobayashi T, Otsuji K, Ohta Y, Nagata M, Ishiguro I. Preventive action of Oren-gedoku-to (Huang-Lian-Jie-Du-Tang) extract on compound 48/80-induced gastric mucosal lesions. J Med Pharm Soc for WAKAN-YAKU (Wakan Iyaku Gakkaishi) 1993; 9: 222-30.
51. Boyd SC, Sasame HA, Boyd MR. High concentrations of glutathione in glandular stomachs. Possible implication for carcinogenesis. Science 1979; 205: 1010-2.
52. Stein HJ, Hinder RA, Oosthuizen MMJ. Gastric mucosal injury caused hemorrhagic shock and reperfusion: Protective role of the antioxidant glutathione. Surgery 1990; 108: 467-74.
53. Casini A, Ceni E, Salano R, Biondi P, Parola M, Call A, Foschi M, Caligiuri A, Pinzani M, Surrent C. Neutrophil-derived superoxide anion induces lipid peroxidation and stimulates collagen synthesis in human hepatic stellate cells: Role of nitric oxide. Hepatology 1997; 25: 361-7.
54. Zimmerman JJ, Ciesielski W, Lewandoski J. Neutrophil-mediated phospholipid peroxidation assessed by gas chromatography-mass spectroscopy. Am J Physiol 1997; 273: C653-61.
55. Carlin GR, Djursater R. Peroxidation of phospholipid promoted by myeloperoxidase. Free Radic Res Commun 1988; 4: 251-7.
56. Stelmaszynska T, Kukovetz E, Egger G, Shaur RJ. Possible involvement of myeloperoxidase in lipid peroxidation. Int J Biochem 1992; 24: 121-8.
57. Parks DA, Granger DN. Xanthine oxidase: Biochemistry, distribution and physiology. Acta Physiol Scand 1986; 548(Suppl): 87-99.
58. Matsukura H, Masuda M, Uchida A, Kamishiro T. Effect of NC-1300-O-3 on gastric mucus secretion and prostaglandin release in rats. Jpn J Pharmacol 1994; 65: 319-26.
59. Ichikawa T, Ishihara K, Saigenji K, Hotta K. Effects of acid-inhibitory antiulcer drugs on mucin biosynthesis in the stomach. Eur J Pharmacol 1994; 251: 107-11.